Merit Medical Systems | MMSI - Spese Di Vendita E Di Amministrazione

Prezzo Delle Azioni
68.58
Cambio Giornaliero
-0.03 -0.04%
Mensile
0.69%
Annuale
-27.51%
Q2 Previsione
67.11




Spese Di Vendita E Di Amministrazione Cambiamento Data
3M USD 744M 221M 2026-03
Abbott USD 3.27B 138M 2026-03
AngioDynamics USD 36.57M 3.79M 2025-09
Anika Therapeutics USD 10.01M 14K 2025-12
AtriCure USD 78.34M 109K 2025-12
Baxter International USD 761M 53M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.83B 93M 2025-12
Cooper Companies USD 373.1M 46.1M 2025-12
Dexcom USD 299.9M 31.5M 2025-12
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Globus Medical USD 318.48M 4.88M 2025-12
Haemonetics USD 109.15M 7.54M 2025-12
ICU Medical USD 155.81M 3.04M 2025-12
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
J&J USD 6.03B 719M 2026-03
Medtronic 2.97B 159M 2025-09
Merit Medical Systems USD 114.83M 7.45M 2025-12
Olympus JPY 125.65B 5.75B 2025-12
Pfizer USD 4.08B 894M 2025-12
STAAR Surgical USD 38.94M 20.44M 2025-12
Stryker USD 2.14B 150M 2025-12
Surmodics USD 11.4M 3.18M 2025-06
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
Terumo JPY 105.26B 7.38B 2025-12
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12